GlaxoSmithKline S.A.E (EGX: BIOC)
Egypt
· Delayed Price · Currency is EGP 42.20
-3.60 (-7.86%)
At close: Oct 15, 2024
GlaxoSmithKline S.A.E Company Description
GlaxoSmithKline S.A.E. engages in the production of pharmaceutical chemicals in Egypt. It is also involved in the manufacture of medical preparations and cosmetics.
The company was founded in 1981 and is headquartered in New Cairo City, Egypt. GlaxoSmithKline S.A.E.
operates as a subsidiary of Glaxo Group Limited.
GlaxoSmithKline S.A.E
| Country | Egypt |
| Founded | 1981 |
| Industry | Pharmaceutical Preparations |
| Employees | 800 |
| CEO | Hassan Fahmi |
Contact Details
Address: Boomerang Building No. 46, Town Centre New Cairo City, 11835 Egypt | |
| Phone | 20 2 618 5000 |
| Website | gsk.com |
Stock Details
| Ticker Symbol | BIOC |
| Exchange | Egyptian Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | EGP |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Hassan Fahmi | Chief Executive Officer |
| Vikas Jain | Chief Financial Officer |
| Mohsen Taoufils | Head of Investor Relations |